- Home
- NBTB vs CNTA Comparison
NBTB vs CNTA Comparison
Compare NBTB & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTB
- CNTA
- Stock Information
- Founded
- NBTB 1856
- CNTA 2020
- Country
- NBTB United States
- CNTA United Kingdom
- Employees
- NBTB N/A
- CNTA N/A
- Industry
- NBTB Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NBTB Finance
- CNTA Health Care
- Exchange
- NBTB Nasdaq
- CNTA Nasdaq
- Market Cap
- NBTB 2.3B
- CNTA 2.3B
- IPO Year
- NBTB N/A
- CNTA 2021
- Fundamental
- Price
- NBTB $47.15
- CNTA $17.50
- Analyst Decision
- NBTB Buy
- CNTA Strong Buy
- Analyst Count
- NBTB 6
- CNTA 7
- Target Price
- NBTB $48.17
- CNTA $23.71
- AVG Volume (30 Days)
- NBTB 288.4K
- CNTA 581.0K
- Earning Date
- NBTB 01-27-2025
- CNTA 11-12-2024
- Dividend Yield
- NBTB 2.88%
- CNTA N/A
- EPS Growth
- NBTB 0.14
- CNTA N/A
- EPS
- NBTB 2.85
- CNTA N/A
- Revenue
- NBTB $538,802,000.00
- CNTA $6,853,000.00
- Revenue This Year
- NBTB N/A
- CNTA N/A
- Revenue Next Year
- NBTB $17.27
- CNTA N/A
- P/E Ratio
- NBTB $16.75
- CNTA N/A
- Revenue Growth
- NBTB 10.23
- CNTA N/A
- 52 Week Low
- NBTB $32.79
- CNTA $6.65
- 52 Week High
- NBTB $52.44
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- NBTB 37.20
- CNTA 53.43
- Support Level
- NBTB $47.43
- CNTA $15.45
- Resistance Level
- NBTB $48.43
- CNTA $18.00
- Average True Range (ATR)
- NBTB 1.40
- CNTA 1.14
- MACD
- NBTB -0.42
- CNTA -0.05
- Stochastic Oscillator
- NBTB 0.63
- CNTA 76.78
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.